1. Home
  2. GLSI
  3. GLSI News

Latest Greenwich LifeSciences Inc. (GLSI) News on August 27, 2025

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences
GLSI

GlobeNewswire

7 days ago

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

GLSI

MT Newswires

8 days ago

Greenwich LifeSciences to Build In-House Clinical Trial Teams to Boost Efficiency

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
GLSI

GlobeNewswire

8 days ago

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team

GLSI

ACCESS Newswire

2 months ago

Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GLSI

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 04/23/2025

Greenwich LifeSciences Provides Global Update on FLAMINGO-01
GLSI

GlobeNewswire

5 months ago

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
GLSI

GlobeNewswire

5 months ago

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

GLSI

MT Newswires

5 months ago

Greenwich LifeSciences Extends Lock-Up Period for Directors, Officers to March 2026

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
GLSI

GlobeNewswire

5 months ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

GLSI

MT Newswires

5 months ago

Greenwich LifeSciences Says Preliminary Safety Data for Breast Cancer Therapy Appears Consistent With Prior Trials

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
GLSI

GlobeNewswire

5 months ago

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01

55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently
GLSI

Simply Wall St.

6 months ago

55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently

GLSI

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/21/2025

GLSI

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/20/2025

GLSI

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/19/2025

GLSI

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/18/2025

GLSI

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/14/2025

GLSI

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/13/2025

GLSI

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/12/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 02/11/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 02/10/2025

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
GLSI

GlobeNewswire

7 months ago

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 02/07/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 02/06/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 02/05/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 02/04/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 02/03/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/31/2025

EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial
GLSI

Clinical Trials Arena

7 months ago

EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/30/2025

GLSI

MT Newswires

7 months ago

Greenwich LifeSciences Gets EU Drug Regulator Approval to Add Sites to GLSI-100 Late-Stage Trial

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/29/2025

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
GLSI

GlobeNewswire

7 months ago

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/28/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/27/2025

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
GLSI

GlobeNewswire

7 months ago

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/24/2025

Bullish Greenwich LifeSciences Insiders Loaded Up On US$3.39m Of Stock
GLSI

Simply Wall St.

7 months ago

Bullish Greenwich LifeSciences Insiders Loaded Up On US$3.39m Of Stock

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/23/2025

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
GLSI

GlobeNewswire

7 months ago

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/22/2025

Greenwich LifeSciences Provides Update on Commercial Manufacturing
GLSI

GlobeNewswire

7 months ago

Greenwich LifeSciences Provides Update on Commercial Manufacturing

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/21/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/17/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/16/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/15/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 01/14/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/14/2025

GLSI

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 01/14/2025

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01
GLSI

GlobeNewswire

7 months ago

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

GLSI

MT Newswires

7 months ago

Greenwich LifeSciences Partners With Unicancer to Activate Sites for Breast Cancer Study in France

Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
GLSI

GlobeNewswire

7 months ago

Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France

GLSI

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 01/13/2025

GLSI

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 01/09/2025

GLSI

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 01/09/2025

GLSI

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 01/08/2025

GLSI

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 01/07/2025

GLSI

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 01/06/2025

GLSI

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 01/03/2025

Greenwich LifeSciences Partners with GIM in Italy
GLSI

GlobeNewswire

9 months ago

Greenwich LifeSciences Partners with GIM in Italy

Greenwich LifeSciences Provides Update on Corporate Events
GLSI

GlobeNewswire

9 months ago

Greenwich LifeSciences Provides Update on Corporate Events

GLSI

Argus Research

10 months ago

Daily – Vickers Top Insider Picks for 10/18/2024

GLSI

Argus Research

10 months ago

Daily – Vickers Top Insider Picks for 10/17/2024

GLSI

Argus Research

10 months ago

Daily – Vickers Top Insider Picks for 10/16/2024

GLSI

Argus Research

10 months ago

Daily – Vickers Top Insider Picks for 10/15/2024

GLSI

Argus Research

10 months ago

Daily – Vickers Top Insider Picks for 10/14/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/11/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/10/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/09/2024

GLSI

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/08/2024

GLSI

MT Newswires

a year ago

Greenwich LifeSciences Files Mixed Shelf Offering

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/07/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/04/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/03/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/02/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 10/01/2024

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders seem bullish, own 55% and have been buying more recently
GLSI

Simply Wall St.

a year ago

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders seem bullish, own 55% and have been buying more recently

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 09/09/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 09/03/2024

GLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 08/26/2024

Insider Stock Buying Reaches US$3.36m On Greenwich LifeSciences
GLSI

Simply Wall St.

a year ago

Insider Stock Buying Reaches US$3.36m On Greenwich LifeSciences

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
GLSI

GlobeNewswire

a year ago

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

GLSI

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 07/25/2024

GLSI

MT Newswires

a year ago

Greenwich LifeSciences to Join Russell 2000 Index; Shares Rise

Greenwich LifeSciences Set to Join Russell 2000 Index Again
GLSI

GlobeNewswire

a year ago

Greenwich LifeSciences Set to Join Russell 2000 Index Again

GLSI

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 06/18/2024

Insider Buying: CEO and CFO Snehal Patel Acquires Shares of Greenwich LifeSciences Inc (GLSI)
GLSI

GuruFocus.com

a year ago

Insider Buying: CEO and CFO Snehal Patel Acquires Shares of Greenwich LifeSciences Inc (GLSI)

GLSI

MT Newswires

a year ago

Greenwich Lifesciences Insider Bought Shares Worth $2,499,998, According to a Recent SEC Filing

GLSI

MT Newswires

a year ago

Greenwich LifeSciences' CEO Acquires $2.5 Million in Shares

Greenwich LifeSciences Announces $2.5 Million Private Placement
GLSI

GlobeNewswire

a year ago

Greenwich LifeSciences Announces $2.5 Million Private Placement

Insiders are Piling into These 10 Healthcare Stocks in 2024
GLSI

Insider Monkey

a year ago

Insiders are Piling into These 10 Healthcare Stocks in 2024

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
GLSI

GlobeNewswire

a year ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
GLSI

GlobeNewswire

a year ago

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares
GLSI

GuruFocus.com

a year ago

Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
GLSI

GlobeNewswire

2 years ago

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

GLSI

Argus Research

2 years ago

Daily – Vickers Top Buyers & Sellers for 02/22/2024

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
GLSI

GlobeNewswire

2 years ago

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
GLSI

GlobeNewswire

2 years ago

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

First Business Financial Services (FBIZ) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
GLSI

Zacks

2 years ago

First Business Financial Services (FBIZ) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Share on Social Networks: